Collin D. Freeman

2.0k total citations
25 papers, 1.5k citations indexed

About

Collin D. Freeman is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Collin D. Freeman has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Pharmacology and 9 papers in Epidemiology. Recurrent topics in Collin D. Freeman's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Collin D. Freeman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Collin D. Freeman collaborates with scholars based in United States. Collin D. Freeman's co-authors include Kenneth C. Lamp, Neil E. Klutman, Richard Quintiliani, David P. Nicolau, C H Nightingale, Paul Belliveau, Jack Ross, Melinda K. Lacy, Charles H. Nightingale and Brian Cooper and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Drugs.

In The Last Decade

Collin D. Freeman

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Collin D. Freeman United States 12 611 500 465 236 203 25 1.5k
Kenneth J. Tack United States 24 490 0.8× 684 1.4× 622 1.3× 271 1.1× 358 1.8× 45 1.6k
Randall S. Edson United States 23 291 0.5× 426 0.9× 671 1.4× 212 0.9× 230 1.1× 57 1.9k
D. S. Reeves United Kingdom 26 699 1.1× 372 0.7× 668 1.4× 457 1.9× 231 1.1× 89 1.8k
Ómar Vesga Colombia 17 529 0.9× 432 0.9× 272 0.6× 356 1.5× 176 0.9× 34 1.3k
Burt R. Meyers United States 27 732 1.2× 671 1.3× 750 1.6× 453 1.9× 235 1.2× 78 2.0k
D. S. Reeves United Kingdom 25 680 1.1× 328 0.7× 438 0.9× 480 2.0× 211 1.0× 94 1.8k
Paul B. Iannini United States 22 333 0.5× 424 0.8× 625 1.3× 288 1.2× 514 2.5× 43 1.6k
Paul Noone United Kingdom 22 489 0.8× 599 1.2× 502 1.1× 277 1.2× 231 1.1× 71 1.9k
D. Daneau Belgium 20 497 0.8× 309 0.6× 505 1.1× 442 1.9× 344 1.7× 53 1.6k
Olaf Burkhardt Germany 27 728 1.2× 422 0.8× 1.0k 2.2× 390 1.7× 221 1.1× 56 2.1k

Countries citing papers authored by Collin D. Freeman

Since Specialization
Citations

This map shows the geographic impact of Collin D. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collin D. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collin D. Freeman more than expected).

Fields of papers citing papers by Collin D. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Collin D. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collin D. Freeman. The network helps show where Collin D. Freeman may publish in the future.

Co-authorship network of co-authors of Collin D. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Collin D. Freeman. A scholar is included among the top collaborators of Collin D. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collin D. Freeman. Collin D. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gotfried, Mark H. & Collin D. Freeman. (2000). An update on community-acquired pneumonia in adults. Comprehensive Therapy. 26(4). 283–293. 3 indexed citations
3.
Lamp, Kenneth C., Collin D. Freeman, Neil E. Klutman, & Melinda K. Lacy. (1999). Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials. Clinical Pharmacokinetics. 36(5). 353–373. 281 indexed citations
4.
Freeman, Collin D., et al.. (1998). Relative Bioavailability of Atovaquone Suspension When Administered with an Enteral Nutrition Supplement. Annals of Pharmacotherapy. 32(10). 1004–1007. 12 indexed citations
5.
Freeman, Collin D., Neil E. Klutman, & Kenneth C. Lamp. (1997). Metronidazole. Drugs. 54(5). 679–708. 379 indexed citations
6.
Freeman, Collin D.. (1997). Antimicrobial Resistance. Critical Care Nursing Quarterly. 20(3). 21–35. 7 indexed citations
7.
Belliveau, Paul, Collin D. Freeman, David P. Nicolau, et al.. (1996). Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias. American Journal of Health-System Pharmacy. 53(9). 1024–1027. 6 indexed citations
8.
Freeman, Collin D., et al.. (1996). Mega‐Analysis of Meta‐Analysis: An Examination of Meta‐Analysis with an Emphasis on Once‐Daily Aminoglycoside Comparative Trials. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(6). 1093–1102. 40 indexed citations
9.
Lipsy, Robert J. & Collin D. Freeman. (1995). Hemodynamic Effects of Intravenous Famotidine in Critically Ill Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(1). 48–51. 1 indexed citations
10.
Freeman, Collin D., Charles H. Nightingale, David P. Nicolau, et al.. (1995). Intracellular and Extracellular Penetration of Azithromycin into Inflammatory and Noninflammatory Blister Fluid. Antimicrobial Agents and Chemotherapy. 39(3). 795–795. 1 indexed citations
11.
Freeman, Collin D., C H Nightingale, & Richard Quintiliani. (1994). Minocycline: old and new therapeutic uses. International Journal of Antimicrobial Agents. 4(4). 325–335. 14 indexed citations
12.
Freeman, Collin D., C H Nightingale, David P. Nicolau, Paul Belliveau, & Richard Quintiliani. (1994). Serum bactericidal activity of ceftriaxone plus metronidazole against common intra-abdominal pathogens.. PubMed. 51(14). 1782–7. 9 indexed citations
13.
Freeman, Collin D., Charles H. Nightingale, David P. Nicolau, Paul Belliveau, & Richard Quintiliani. (1994). Serum bactericidal activity of ceftriaxone plus metronidazole against common intra-abdominal pathogens. American Journal of Health-System Pharmacy. 51(14). 1782–1787. 1 indexed citations
14.
Freeman, Collin D., Charles H. Nightingale, David P. Nicolau, et al.. (1994). Bactericidal Activity of Low‐Dose Ceftizoxime Plus Metronidazole Compared With Cefoxitin and Ampicillin‐Sulbactam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(2). 185–190. 8 indexed citations
15.
Nicolau, David P., et al.. (1994). Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 38(7). 1515–1518. 30 indexed citations
16.
Freeman, Collin D., Richard Quintiliani, & Charles H. Nightingale. (1993). Vancomycin Therapeutic Drug Monitoring. Annals of Pharmacotherapy. 27(5). 594–598. 78 indexed citations
17.
Freeman, Collin D., David P. Nicolau, Paul Belliveau, & C H Nightingale. (1993). Lomefloxacin Clinical Pharmacokinetics. Clinical Pharmacokinetics. 25(1). 6–19. 9 indexed citations
18.
Nicolau, David P., Collin D. Freeman, C H Nightingale, et al.. (1993). Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infection and Immunity. 61(4). 1593–1595. 54 indexed citations
19.
Nicolau, David P., Collin D. Freeman, C H Nightingale, & Richard Quintiliani. (1993). Pharmacokinetics of minocycline and vancomycin in rabbits.. PubMed. 43(3). 222–5. 10 indexed citations
20.
Freeman, Collin D.. (1992). Drug treatment of insomnia in the elderly.. PubMed. 56(1). 35–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth J. Tack Breakdown of academic impact, for papers by Randall S. Edson Breakdown of academic impact, for papers by D. S. Reeves Breakdown of academic impact, for papers by Ómar Vesga Breakdown of academic impact, for papers by Burt R. Meyers Breakdown of academic impact, for papers by D. S. Reeves Breakdown of academic impact, for papers by Paul B. Iannini Breakdown of academic impact, for papers by Paul Noone Breakdown of academic impact, for papers by D. Daneau Breakdown of academic impact, for papers by Olaf Burkhardt
Rankless by CCL
2026